Checchi Capital Advisers, LLC Amgen Inc Transaction History

Checchi Capital Advisers, LLC

  • $1.78 Billion
  • Q3 2024

A detailed history of Checchi Capital Advisers, LLC transactions in Amgen Inc stock. As of the latest transaction made, Checchi Capital Advisers, LLC holds 6,657 shares of AMGN stock, worth $1.9 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
6,657
Previous 6,841 2.69%
Holding current value
$1.9 Million
Previous $2.14 Million 0.33%
% of portfolio
0.12%
Previous 0.11%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024
SELL
$309.38 - $337.38 $56,925 - $62,077
-184 Reduced 2.69%
6,657 $2.14 Million
Q2 2024

Jul 26, 2024
BUY
$262.75 - $319.31 $26,537 - $32,250
101 Added 1.5%
6,841 $2.14 Million
Q1 2024

Apr 25, 2024
SELL
$268.87 - $324.56 $64,797 - $78,218
-241 Reduced 3.45%
6,740 $1.92 Million
Q4 2023

Feb 07, 2024
BUY
$255.7 - $288.46 $25,314 - $28,557
99 Added 1.44%
6,981 $2.01 Million
Q3 2023

Nov 09, 2023
SELL
$218.65 - $271.46 $39,357 - $48,862
-180 Reduced 2.55%
6,882 $1.85 Million
Q2 2023

Aug 09, 2023
SELL
$214.27 - $253.37 $35,783 - $42,312
-167 Reduced 2.31%
7,062 $1.57 Million
Q1 2023

May 05, 2023
SELL
$225.79 - $275.2 $37,255 - $45,408
-165 Reduced 2.23%
7,229 $1.75 Million
Q4 2022

Feb 10, 2023
SELL
$229.03 - $291.01 $204,523 - $259,871
-893 Reduced 10.78%
7,394 $1.94 Million
Q3 2022

Nov 09, 2022
BUY
$224.46 - $253.15 $11,447 - $12,910
51 Added 0.62%
8,287 $1.87 Million
Q2 2022

Aug 11, 2022
BUY
$230.71 - $256.74 $293,924 - $327,086
1,274 Added 18.3%
8,236 $2.04 Million
Q1 2022

May 09, 2022
BUY
$219.27 - $242.57 $137,263 - $151,848
626 Added 9.88%
6,962 $1.68 Million
Q4 2021

Feb 09, 2022
SELL
$198.88 - $227.6 $16,109 - $18,435
-81 Reduced 1.26%
6,336 $1.43 Million
Q3 2021

Nov 09, 2021
SELL
$212.27 - $248.7 $18,255 - $21,388
-86 Reduced 1.32%
6,417 $1.37 Million
Q2 2021

Aug 06, 2021
SELL
$233.58 - $259.14 $78,249 - $86,811
-335 Reduced 4.9%
6,503 $1.59 Million
Q1 2021

May 10, 2021
SELL
$221.91 - $258.6 $17,530 - $20,429
-79 Reduced 1.14%
6,838 $1.7 Million
Q4 2020

Feb 12, 2021
SELL
$216.38 - $257.67 $13,199 - $15,717
-61 Reduced 0.87%
6,917 $1.59 Million
Q3 2020

Nov 10, 2020
SELL
$234.65 - $260.95 $18,537 - $20,615
-79 Reduced 1.12%
6,978 $1.77 Million
Q2 2020

Aug 12, 2020
SELL
$197.81 - $242.74 $58,749 - $72,093
-297 Reduced 4.04%
7,057 $1.66 Million
Q1 2020

May 07, 2020
BUY
$182.24 - $241.7 $116,269 - $154,204
638 Added 9.5%
7,354 $1.49 Million
Q4 2019

Feb 07, 2020
BUY
$189.21 - $243.2 $60,547 - $77,824
320 Added 5.0%
6,716 $1.62 Million
Q3 2019

Nov 06, 2019
SELL
$174.11 - $208.62 $174 - $208
-1 Reduced 0.02%
6,396 $1.24 Million
Q2 2019

Aug 06, 2019
SELL
$166.7 - $195.41 $71,347 - $83,635
-428 Reduced 6.27%
6,397 $1.18 Million
Q1 2019

May 09, 2019
SELL
$180.87 - $203.88 $41,600 - $46,892
-230 Reduced 3.26%
6,825 $1.3 Million
Q4 2018

Feb 07, 2019
SELL
$178.4 - $208.25 $65,829 - $76,844
-369 Reduced 4.97%
7,055 $1.37 Million
Q3 2018

Oct 29, 2018
BUY
$185.29 - $208.89 $174,357 - $196,565
941 Added 14.51%
7,424 $1.54 Million
Q2 2018

Aug 06, 2018
BUY
$166.05 - $186.51 $27,398 - $30,774
165 Added 2.61%
6,483 $1.2 Million
Q1 2018

May 01, 2018
SELL
$169.43 - $198.0 $186,034 - $217,404
-1,098 Reduced 14.81%
6,318 $1.08 Million
Q4 2017

Feb 02, 2018
BUY
$168.79 - $188.59 $175,372 - $195,945
1,039 Added 16.29%
7,416 $1.29 Million
Q3 2017

Nov 02, 2017
BUY
$167.29 - $191.0 $1.07 Million - $1.22 Million
6,377
6,377 $1.19 Million

Others Institutions Holding AMGN

# of Institutions
3,084
Shares Held
401M
Call Options Held
7.56M
Put Options Held
7.16M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $153B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Checchi Capital Advisers, LLC Portfolio

Follow Checchi Capital Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Checchi Capital Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Checchi Capital Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email